Director/PDMR Shareholding

AstraZeneca PLC 28 March 2006 Transaction by Persons Discharging Managerial Responsibilities Disclosure Rules DR 3.1.2R We hereby inform you that on 24 March 2006 the following individuals, who are all persons discharging managerial responsibilities, were granted options under the AstraZeneca Share Option Plan over the Company's USD0.25 Ordinary Shares or, in the case of A Zook, over the Company's American Depositary Shares (ADSs). One ADS equals one Ordinary Share Number of shares Exercise price Period when over which option per share exercisable Name of individual is granted B Angelici 36,048 2975p 24.3.09-23.3.16 A P Bloxham 18,519 2975p 24.3.09-23.3.16 J Lundberg 23,068 2975p 24.3.09-23.3.16 M Nicklasson 23,092 2975p 24.3.09-23.3.16 B J Thorpe 18,496 2975p 24.3.09-23.3.16 A Zook 51,676 US$51.73 24.3.09-23.3.16 The options will become exercisable on 24 March 2009 subject to certain performance conditions. The conditions, which will not be subject to any retesting, are that the earnings per share of the Company must increase by the increase in the UK Retail Prices Index plus 5% per annum on average over three years, and that no significant unforeseen event has taken place which, in the reasonable opinion of the Remuneration Committee, has resulted in major reputational damage to AstraZeneca, and the circumstances of which are exceptional enough to justify the option not vesting and becoming exercisable. Failure to satisfy either or both of these conditions will result in the lapse of the option in its entirety. G H R Musker Company Secretary 28 March 2006 This information is provided by RNS The company news service from the London Stock Exchange

Companies

AstraZeneca (AZN)
UK 100

Latest directors dealings